GM2 Gangliosidosis
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2 (NCT04470713) | Idorsia Pharmaceuticals Ltd. | 2019-07-31 |
| N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease) (NCT03759665) | IntraBio Inc | 2019-06-07 |
| Effects of Miglustat Therapy on Infantile Type of Sandhoff and Taysachs Diseases (EMTISTD) (NCT03822013) | Tehran University of Medical Sciences | 2019-01-14 |
| LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies (NCT02699190) | Children's Hospital of Philadelphia | 2017-01-06 |
| The Myelin Disorders Biorepository Project (NCT03047369) | Children's Hospital of Philadelphia | 2016-12-08 |
| A Natural History of Late Onset Tay-Sachs Disease (NCT02851862) | Massachusetts General Hospital | 2016-04-01 |
Track GM2 Gangliosidosis automatically
Every clearance here is in the API, with alerts when new ones post.